Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
TSEN34 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
Invitae Brain Malformations Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 247 | 161 |
|
PreventionGenetics, part of Exact Sciences United States | 79 | 52 |
|
Pontocerebellar Hypoplasia Panel PreventionGenetics, part of Exact Sciences United States | 14 | 12 |
|
Pontocerebellar Hypoplasia via the TSEN34 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 1 | 1 |
|
Brain Malformations Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 111 | 56 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 67 | 48 |
|
Pontocerebellar hypoplasia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 20 | 18 |
|
Fulgent Genetics United States | 509 | 275 |
|
PONTOCEREBELLAR HYPOPLASIA TYPE 2 Laboratorio de Genetica Clinica SL Spain | 3 | 3 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.